CUDC-907 is a dual PI3K and HDAC inhibitor. Studies have shown CUDC-907 is able to enhance antitumor activity when combined with standard of care agents in multiple myeloma and B cell lymphoma xenograft models.
Molecular Weight:
508.55
CAS Number:
[1339928-25-4]
* VAT and and shipping costs not included. Errors and price changes excepted